Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...

As previously reported, Craig-Hallum initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target Interest in weight loss ...

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio ...

The TrueScience® TruePout Hydrating Lip Oil will be available exclusively through US Consultants and on the LifeVantage website. Supplies are limited, and customers are encouraged to act quickly ...

Detailed price information for Lifevantage Corp (LFVN-Q) from The Globe and Mail including charting and trades.

LifeVantage's (NASDAQ:LFVN) stock is up by a considerable 55% over the past three months. Given that stock prices are usually aligned with a company's financial performance in the long-term, we ...

LifeVantage (NASDAQ:LFVN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the ...

LifeVantage (LFVN) Corporation announces the addition of Todd Thompson as Chief Information and Innovation Officer. Todd brings decades of experience driving transformative technology solutions ...

As of December 23, 2024, the average one-year price target for LifeVantage is $26.52/share. The forecasts range from a low of $26.26 to a high of $27.30. The average price target represents an ...